-200x200.jpg "Accu-Chek Active (50 Strips)")
Axim CV 250 mg Tab
Cefuroxime has bactericidal activity against a wide range of bacteria, including beta-lactamase producing strains. The bactericidal action of Cefuroxime results from inhibition of cell wall synthesis by binding to essential target proteins. Cefuroxime has good stability to bacterial beta-lactamases.Clavulanic acid is a naturally derived beta lactamase inhibitor produced by Streptomyces clavuligerus. It has similar structure to beta lactam antibiotics but binds irreversibly to beta-lactamase enzymes and inactivates them. Clavulanic acid gives protection of Cefuroxime from degradation by beta lactamase enzymes and provides a solution for the treatment of bacterial infections caused by beta lactam resistant bacteria...
Tk.30.00/=
Azithrocin 250 Tablet
Azithrocin® contains Azithromycin U.S.P. It is an azalide antibiotics active against Gram-positive and gram negative organisms. Azithrocin® (Azithromycin) in indicated for infections caused by susceptible organisms; In lower respiratory tract infections including bronchitis and pneumonia, skin and soft tissue infections, otitis media and in upper respiratory tract infections including sinusitis, pharyngitis and tonsillitis. In sexually transmitted disease in men and women Azithrocin® (Azithromycin) is indicated in the treatment of uncomplicated genital infections due to Chlamydia trachomatis. Azithrocin® has very simple once daily dosage schedule for 3 days only, which is very convenient for the patients.Azithrocin 250 Tab..
Tk.25.00/=
Azithrocin 500 IV
Azithrocin® IV contains Azithromycin lyophilized powder USP for IV infusion. It is an azalide antibiotic active against Gram-positive and Gram-negative organisms. Azithromycin interferes with ribosome function in susceptible bacteria by inhibiting the translocation of peptides. Intravenous Azithrocin® is indicated to treat Community-acquired pneumonia in patients who require initial intravenous therapy. It is also indicated for Pelvic inflammatory disease in patients who require initial intravenous therapy...
Tk.460.00/=
